Trade JnJ ^JNJ

Morgan Stanley cuts Intra-Cellular stock rating to Equalweight post JNJ acquisition By Investing.com

News Highlights: Top Company News of the Day - Monday at 9 AM ET | Morningstar

Intra-Cellular Therapies Inc (ITCI) Under Investigation for Proposed Sale to Johnson & Johnson

52,874 Shares in Johnson & Johnson (NYSE:JNJ) Purchased by Clark & Stuart Inc

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations | The Manila Times

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones | The Manila Times

Czech National Bank Acquires 31,640 Shares of Johnson & Johnson (NYSE:JNJ)

HEALTHCARE: Johnson & Johnson (JNJ: Aaa/AAA neg)

Johnson & Johnson To Buy Intra-Cellular Therapies For $132.00/shr In $14.6 Bln All-cash Deal

J&J (JNJ) to buy Intra-Cellular Therapies (ITCI)

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc. | The Manila Times

J&J to acquire drugmaker Intra-Cellular Therapies for $14.6 billion | Company News - Business Standard

Morgan Stanley reaffirms JNJ equalweight stock rating on recent deal By Investing.com

ORIC Pharmaceuticals advances cancer drug trials By Investing.com

J&J to buy Intra-Cellular Therapies for $14.6 billion By Reuters

Johnson & Johnson in talks to acquire Intra-Cellular Therapies By Investing.com

Johnson & Johnson is in talks to buy US$10 billion biotech Intra-Cellular

J&J explores takeover bid for Intra-Cellular Therapies, Bloomberg reports By Investing.com

Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ) | Markets Insider

Johnson & Johnson (NYSE:JNJ) Receives Average Rating of "Hold" from Brokerages

Johnson & Johnson (NYSE:JNJ) Trading Down 2.8% - Should You Sell?

RMR Wealth Builders Sells 157 Shares of Johnson & Johnson (NYSE:JNJ)

Graypoint LLC Acquires 344 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Position Lessened by Lynch & Associates IN

Cramer on Johnson & Johnson (JNJ): A Value Trap Amid Lawsuits and Setbacks

Harbor Capital Advisors Inc. Grows Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Trading 0.8% Higher - Here's Why

Johnson & Johnson (NYSE:JNJ) Stock Acquired Rep. Lloyd Doggett

Accessing ultrastable glass via a bulk transformation

FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab - January 10, 2025 - Zacks.com

J&J Talc Unit Objects to Committee Bid to Hire Brown Rudnick

Johnson & Johnson (NYSE:JNJ) Stock Price Down 2.8% - Here's Why

Johnson & Johnson (NYSE:JNJ) Stock Acquired Rep. Virginia Foxx

Johnson & Johnson Gets FDA Priority Review of Nipocalimab in Generalized Myasthenia Gravis | Morningstar

Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis | Morningstar

Johnson&Johnson, UnitedHealth lead Thursday's market cap stock movers By Investing.com

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - January 9, 2025 - Zacks.com

J&J pauses Varipulse cases on stroke concerns | BioWorld

Varipulse Heart Device Procedures Paused After Safety Events | MedPage Today

Farmers Trust Co. Decreases Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Price Down 2.3% - Here's Why

Douglas Lane & Associates LLC Purchases 6,526 Shares of Johnson & Johnson (NYSE:JNJ)

InvesTrust Buys New Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Down 2.3% - Should You Sell?

Johnson & Johnson (NYSE:JNJ) Hits New 52-Week Low - Should You Sell?

Johnson & Johnson stock reaches 52-week low as markets fall

International Assets Investment Management LLC Sells 3,433,146 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson on Track for Lowest Close Since November 2020 - Data Talk | Morningstar

J&J's Posdinemab Granted FDA Fast Track Designation For Alzheimer's Treatment | Markets Insider

Park National Corp OH Sells 10,706 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's | Morningstar

Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease | Morningstar

AMD, J&J lead market cap stock movers on Wednesday By Investing.com

Johnson & Johnson price target lowered to $160 from $177 at Bernstein | Markets Insider

Johnson & Johnson stock sinks on Varipulse concerns By Investing.com

Johnson & Johnson stock hits 52-week low at $142.7 By Investing.com

Stock Analysts' Downgrades for January 7th (ADC, CACC, E, JNJ, LPL, MLKN, MORN, MSBHY, NBTB, PENN)

Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease By Investing.com

Johnson & Johnson (NYSE:JNJ) Downgraded by StockNews.com to Buy

J&J gains FDA Fast Track for Alzheimer's treatments By Investing.com

The Zacks Analyst Blog Highlights NVIDIA, Meta Platforms, Johnson & Johnson, Rave Restaurant and EVI Industries - January 8, 2025 - Zacks.com

Yuhan, Oscotec stock gains as J&J hits 'gold standard' in NSCLC | BioWorld

Range Financial Group LLC Purchases 11,167 Shares of Johnson & Johnson (NYSE:JNJ)

US Urinary Tract Infection Therapeutics Market Analysis and Research Report by Experts 2025-2033 | Taiwan News | Jan. 8, 2025 03:54

US Contact Lenses Market Key Players, Growth Analysis during 2025-2033 | Taiwan News | Jan. 8, 2025 03:47

Johnson & Johnson (NYSE:JNJ) Shares Up 1.9% - What's Next?

Birch Capital Management LLC Reduces Stake in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Position Decreased by Regent Peak Wealth Advisors LLC

Pittsburgh Jury Tries to Award $22M Against J&J in Talc Case Despite Handing Up Defense Verdict

Chemo-Free Treatment Extends Lung Cancer Survival

Diversified Trust Co Has $12.95 Million Holdings in Johnson & Johnson (NYSE:JNJ)

Amivantamab Plus Lazertinib Improves OS in EGFR-Mutant Advanced NSCLC

J&J Says Lung Cancer Combo Improves Survival More Than Standard of Care

ONL Therapeutics Appoints Penny Fleck as Chief Development Officer | The Manila Times

Bright Minds Biosciences Appoints Stephen Collins as Chief Medical Officer By Investing.com

Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson

Japan's Kaken Pharma enters into license agreement for STAT6 inhibitor with Johnson & Johnson for $1.2 B

Symbol: JNJ Security name: Johnson & Johnson CDR (CAD H

Johnson & Johnson (NYSE:JNJ) Trading Down 0.2% - Here's What Happened

Pensionfund Sabic Raises Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Nordea Investment Management AB Increases Stock Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson Plans Quarterly Dividend of $1.24 (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Down 0% - Time to Sell?

Johnson & Johnson, Kaken Pharmaceutical Strike Licensing Agreement for the STAT6 Program That Targets Autoimmune, Allergic Diseases

Johnson & Johnson (NYSE:JNJ) Shares Sold by Centre Asset Management LLC

Johnson & Johnson (NYSE:JNJ) Shares Sold by GAMMA Investing LLC

Johnson & Johnson's Quarterly Earnings Preview: What You Need to Know

Johnson & Johnson (NYSE:JNJ) Trading 0.2% Higher After Dividend Announcement

Johnson & Johnson (NYSE:JNJ) to Issue $1.24 Quarterly Dividend

Johnson & Johnson Declares $1.24 Quarterly Dividend; 3.4% Yield By Investing.com

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space | BioWorld

Johnson & Johnson (NYSE:JNJ) Sees Significant Decrease in Short Interest

Johnson & Johnson (NYSE:JNJ) Trading 0.9% Higher - Here's What Happened

Johnson & Johnson (NYSE:JNJ) Shares Up 0.9% - Should You Buy?

Morning Note: U.S. Jobs Surge Spurs Dollar Rally, Shakes Global Markets

Week ahead: US and Eurozone Inflation, Chinese GDP and Financial Sector Earnings.

Morning Note: Canada's Employment Data and USD/CAD Movements

IonQ stock News today: IonQ Stock Surges 780% within 6 months

TCS share price highlights: TCS is set to announce Q3 results today

Gold price today: Gold Near 4-Week High Amid Soft US Employment Data

Morning Note: Apple’s Bearish Turn: What’s Behind the Stock’s Downward Shift?

U.S. Q4 GDP Growth Projected to Slow Following Robust Q3 Increase